Martingale Asset Management’s Oxford Immunotec Global OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-17,400
Closed -$290K – 1052
2019
Q3
$290K Sell
17,400
-149,312
-90% -$2.06M ﹤0.01% 939
2019
Q2
$2.3M Buy
166,712
+1,200
+0.7% +$18.4K 0.02% 559
2019
Q1
$2.85M Buy
165,512
+48,300
+41% +$764K 0.03% 507
2018
Q4
$1.5M Buy
+117,212
New +$1.78M 0.02% 611

Other funds holding OXFD

Martingale Asset Management's OXFD Position: Q4 2019 in Review

Martingale Asset Management sold out of Oxford Immunotec Global (OXFD) in Q4 2019, closing a stake of 17,400 shares — an estimated $290K sold.

Martingale Asset Management first reported a position in OXFD in Q4 2018 and held it in 4 quarters. The position peaked at $2.85M in Q1 2019. 68 funds tracked by Wall St. Rank hold OXFD as of Q4 2019.

  • Martingale Asset Management reported no remaining Oxford Immunotec Global position as of Q4 2019 after selling out during the quarter.
  • Martingale Asset Management sold 17,400 Oxford Immunotec Global shares in Q4 2019, an estimated $290K.
  • Martingale Asset Management first reported a position in Oxford Immunotec Global in Q4 2018 and held it in 4 quarters.
  • Martingale Asset Management's Oxford Immunotec Global position peaked at $2.85M in Q1 2019.
  • 68 funds tracked by Wall St. Rank held Oxford Immunotec Global as of Q4 2019.

Based on Martingale Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.